- Advertisement -

Find a job

Subscribe for free

All things Pharma

Emma Hedges

Emma Hedges is a Business Insights Manager at E4H #WeAreE4H
43 POSTS

The first self-administered B-cell therapy for patients with relapsing forms of MS

Novartis receives European and UK licence for Kesimpta®▼(ofatumumab) Ofatumumab is...

MHRA new advice on possible link between COVID-19 Vaccine AstraZeneca and blood clots

The benefits of vaccination continue to outweigh any risks...

MOST READ ON PF

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription